PE
BSX icon

PCM Encore’s Boston Scientific BSX Stock Holding History

PCM Encore’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
5,606
+1,354
+32% +$73.5K 0.04% 391
2026
Q1 		$267K Hold
4,252
– – 0.05% 346
2025
Q4 		$405K Buy
+4,252
New +$417K 0.09% 234

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

PCM Encore's BSX Position: Q2 2026 in Review

PCM Encore increased its Boston Scientific (BSX) stake by 32% in Q2 2026, buying an estimated $73.5K and bringing the position to 5,606 shares worth $239K. The position accounts for 0.04% of the portfolio, ranked #391.

PCM Encore first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $405K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • PCM Encore held 5,606 shares of Boston Scientific worth $239K as of Q2 2026.
  • PCM Encore bought 1,354 Boston Scientific shares in Q2 2026, an estimated $73.5K.
  • Boston Scientific made up 0.04% of PCM Encore's portfolio in Q2 2026, its #391 holding.
  • PCM Encore first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • PCM Encore's Boston Scientific position peaked at $405K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on PCM Encore's 13F filing for Q2 2026, filed 11 Aug 2026.